India, July 24 -- A new study published in The BMJ by researchers from the University of Pennsylvania examined whether GLP-1 weight-loss drugs are linked to a higher risk of hair loss compared with two other commonly used diabetes medicines.
The researchers compared 12,004 people taking GLP-1 drugs with 15,221 people using SGLT-2 inhibitors. They also compared another 11,964 GLP-1 users with 11,233 people taking DPP-4 inhibitors. After accounting for factors such as age and weight, the study found that people taking GLP-1 drugs had a 37 percent higher risk of developing alopecia than those using SGLT-2 inhibitors. Compared with DPP-4 inhibitors, GLP-1 drugs were linked to a 68 percent higher risk of hair loss.
According to the team, the m...